Who owns Rigel Pharmaceuticals?
Key information on Rigel Pharmaceuticals (Ticker: RIGL)
Who owns Rigel Pharmaceuticals?
Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.
- Wellington Management Company owns 9.42M shares worth $63.94M
- BVF owns 8.70M shares worth $59.06M
- OppenheimerFunds owns 6.00M shares worth $40.74M
- T. Rowe Price Associates owns 4.99M shares worth $33.87M
- Vanguard owns 4.63M shares worth $31.45M
- NEA Management Company owns 3.24M shares worth $22.05M
- Palo Alto Investors owns 2.91M shares worth $19.77M
- STATE STREET CORPORATION owns 2.47M shares worth $16.80M
- Millennium Management owns 1.94M shares worth $13.18M
- Deerfield Management Company owns 1.90M shares worth $12.89M
- Broadfin Capital owns 1.68M shares worth $10.90M
- HealthCor Management owns 1.50M shares worth $13.76M
- Ameriprise Financial owns 1.15M shares worth $10.65M
- Royce & Associates owns 795900 shares worth $5.40M
- D. E. Shaw & Co owns 756829 shares worth $5.14M
- Visium Asset Management owns 713201 shares worth $4.85M
- HealthCor Management owns 625000 shares worth $5.81M
- Dr. Jeffrey R. Jay, M.D owns 591817 shares worth $6.06M
- Jennison Associates owns 576402 shares worth $5.91M
- CITADEL ADVISORS owns 559104 shares worth $3.80M
- Norges Bank Investment Management owns 481469 shares worth $3.80M
- GOLDMAN SACHS owns 383967 shares worth $2.61M
- TIAA-CREF Investment Management owns 361788 shares worth $2.46M
- Geode Capital Management owns 349599 shares worth $2.37M
- Barclays owns 339789 shares worth $2.31M
Who sold Rigel Pharmaceuticals?
- FMR sold on Dec. 31, 2010
- Inves sold on Dec. 31, 2010
- Diamondback Capital Management sold on Dec. 31, 2009
Funds that own RIGL also own:
- Amgen (AMGN)
- Array BioPharma (ARRY)
- ArQule (ARQL)
- Exelixis (EXEL)
- ISIS Pharmaceuticals (ISIS)
- Nektar Therapeutics (NKTR)
- Pain Therapeutics (PTIE)
- Cytokinetics (CYTK)
- Rigel Pharmaceuticals (RIGL)
- Targacept (TRGT)
- Flamel Technologies S.A. (FLML)
- Ironwood Pharmaceuticals (IRWD)
- Myrexis (MYRX)
- Transcept Pharmaceuticals (TSPT)
- AVANIR Pharmaceuticals (AVNR)
- NeurogesX (NGSX)
- ACADIA Pharmaceuticals (ACAD)
- Capstone Therapeutics (CAPS)
- Palatin Technologies (PTN)
- Oncothyreon (ONTY)
- Cadus Corporation (KDUS)